Key points from article :
A drug called Remofuscin could be an effective treatment for Stargardt disease, preventing sight loss caused by the condition.
Drug contains Soraprazan, which remove lipofuscin that builds up in the macula and damages the eye cells.
Phase II clinical trial is testing the effectiveness and long-term effects of the drug.
Andrew Lotery of the University of Southampton said: “Results of this clinical trial will be available in another year, but I’m hopeful within a year to 18 months we will see what effect the drug has.”
If the drug does work, the next step would be to hold a phase III study with a larger group of patients.
European Commission hope the drug to potentially “slow or stop disease progression or even improve the disease status of patients.”
